Previous 10 | Next 10 |
– Conference Call and Webcast to Follow at 5:00 p.m. EDT / 2:00 p.m. PDT – Exelixis, Inc. (NASDAQ: EXEL) announced today that its second quarter 2019 financial results will be released on Wednesday, July 31, 2019 after the markets close. At 5:00 p.m. EDT / 2:00 p.m. PDT...
– Original metastatic castration-resistant prostate cancer and immunotherapy-refractory non-small cell lung cancer cohorts expanded to 80 subjects – – Four cohorts added for metastatic castration-resistant prostate cancer based on encouraging early data ...
Exelixis (NASDAQ: EXEL ) -3% after-hours on news that IMspire170, the phase 3 trial evaluating the combination of cobimetinib and atezolizumab, did not meet its primary endpoint of progression-free survival compared to the current standard of care in patients with previously untreated BR...
The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts ...
Based in San Francisco, Exelixis ( EXEL ) is a drug company that is dedicated to the discovery, development and commercialization of new medicines for cancer treatment, asserts Mark Skousen , growth stock expert and editor of Five-Star Trader . The compamy has three commercially...
Exelixis, Inc. (EXEL) William Blair 39th Annual Growth Stock Conference June 05, 2019, 05:00 PM ET Company Participants Chris Senner - Chief Financial Officer Andrew Peters - V.P. of Strategy Conference Call Participants Presentation Operator Okay. I think we’l...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you can re...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The week ahead sees Apple (AAPL) host its annual WWDC conference, Walmart (WMT) hol...
̶ Presentations to be webcast on www.exelixis.com ̶ Exelixis, Inc. (Nasdaq: EXEL) today announced that the company will be presenting at the following three investor conferences in June 2019: William Blair 39 th Annual Growth Stock Conference: Exel...
Exelixis, Inc. ( EXEL ), a mid-sized pharmaceutical, is a strong buy, forecast to double in the next five years, with potential to do much better than that. Analysis E XEL is intriguing on several counts. First, it came through a simple screen for ((A)) FDA-approved drugs, ((B)) positiv...
News, Short Squeeze, Breakout and More Instantly...
– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT – Exelixis, Inc. (Nasdaq: EXEL) announced today that its second quarter 2024 financial results will be released on Tuesday, August 6, 2024 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Ex...
2024-07-11 08:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...